|
0
|
|
Real-World Effectiveness of RSVpreF and RSVpreF3 Vaccines in Preventing Hospitalization and Emergency Department Visits Associated With Respiratory Syncytial Virus in Older Adults: A Meta-analysis.
(academic.oup.com)
|
Sumsuzzman DM
…
Moghadas SM
Clinical Infectious Diseases
2026-05-20
|
#vaccination
#meta-analysis
#rsv
#elderly
#effectiveness
|
|
0
|
|
Overlapping Clinical Presentation of Long COVID and Postacute COVID-19 Vaccination Syndrome: Phenotypes, Severity, and Biomarkers.
(academic.oup.com)
|
Purpura L
…
Yin MT
Clinical Infectious Diseases
2026-05-20
|
#vaccination
#biomarker
#cytokine
#autoimmunity
#long covid
|
|
0
|
|
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged >/=60 Years.
(academic.oup.com)
|
Mitha E
…
Hulstrom V
Clinical Infectious Diseases
2026-05-20
|
#vaccination
#clinical trial
#immunogenicity
#safety
#rsv
|
|
0
|
|
Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old.
(academic.oup.com)
|
Winokur P
…
Kitchin N
Clinical Infectious Diseases
2026-05-20
|
#covid-19
#vaccination
#immunity
#immunogenicity
#safety
|
|
0
|
|
Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345.
(academic.oup.com)
|
Mayer EF
…
Priddy F
Clinical Infectious Diseases
2026-05-20
|
#immunosuppression
#vaccination
#transplantation
#immunogenicity
|